A Placebo- and Active Controlled Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (P04938)

Clinical trial NCT01155466 · COMPLETED

Trial details

NCT number: NCT01155466
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2010-07-14
Primary completion: 2012-12-20
Enrollment: 778

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.